Clinical Trial Update: A Prospective, Non-Randomized, Evaluation of Low-Risk Patients Undergoing Carotid Stenting With ANgiomax (Bivalirudin) [NA]

View source ↗

Summary

Provides an update on a prospective, non-randomized evaluation of using Angiomax (bivalirudin) in low-risk patients undergoing carotid stenting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Stenosis

Drugs mentioned

• Angiomax (bivalirudin)

Snippet

Sponsor: SPSI d.b.a Capital Cardiovascular Associates | Conditions: Carotid Stenosis | NA | Status: UNKNOWN